Table 3.
The abdominal involvement for each patient with Osler–Weber–Rendu disease.
| Patient No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hepatomegaly | + | + | + | + | + | + | + | + | + | + | + | + | − | + | 13 |
| Splenomegaly | − | − | − | − | − | + | − | − | + | − | + | − | − | − | 3 |
| Cirrhotic liver | − | + | + | − | − | − | − | − | − | + | + | + | − | − | 5 |
| HA diameter (mm) | + | 14 | 13 | − | − | 12 | 11 | 11 | 10 | 13 | 14 | + | 14 | 10 | Mean −12.2 |
| Dilated/tortuous intrahepatic artery branches | + | + | + | − | − | − | − | − | − | + | + | + | − | − | 6 |
| HA to HV shunting | + | + | + | + | + | + | − | + | + | − | + | + | + | − | 11 |
| HA to PV shunting | + | + | + | − | − | − | − | − | − | − | + | + | − | − | 5 |
| PV to PV shunting | − | + | + | − | − | − | − | − | − | − | − | − | − | − | 2 |
| Intrahepatic telangiectasis | + | + | + | + | + | + | − | + | + | + | + | + | + | − | 12 |
| Splenic artery thrombosis | + | − | + | − | − | − | − | − | + | − | − | − | − | − | 3 |
| Heterogenous enhancement on arterial phase | + | + | + | + | + | − | − | + | + | + | + | + | − | − | 10 |
| PV enlargement | − | + | + | − | − | + | − | − | + | − | + | + | − | − | 6 |
| HV enlargement | + | + | + | + | − | − | − | + | + | + | + | + | − | − | 10 |
| Collateral circulation | + | + | − | − | − | − | − | + | + | − | + | − | − | − | 5 |
| IHBD dilatations | − | + | + | − | − | + | + | − | − | + | − | − | − | − | 5 |
| Biliary cyst | − | − | − | − | − | − | − | + | − | − | − | − | − | − | 1 |
| Hemangioma | − | + | + | + | − | + | − | + | + | − | − | − | − | − | 6 |
| Nodular hyperplasia | − | + | − | − | − | − | − | − | − | + | − | − | − | − | 2 |
| Ascites | − | + | + | + | − | − | − | + | − | + | + | − | − | + | 7 |
+, the sign is present; −, the sign is not present; HA—hepatic artery; HV—hepatic vein; IHBD—intrahepatic biliary ducts; PV—portal vein.